Andrew Dreyfus - 10 Jun 2025 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Reporting relationship: Director
Issuer ticker: IRWD
Reported as of: 10 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2025, 16:26:22 UTC
Prior SEC filing: 15 May 2025
Next SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Tessler, Attorney-in-Fact

Key filing fact

Andrew Dreyfus filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 12 Jun 2025.

Key facts

This page summarizes Andrew Dreyfus's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2025, 16:26.

Change

Previous filing in this sequence was filed on 15 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001670893 Primary reporting owner

Dreyfus Andrew

Relationship: Director
Address: C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON
Signature: /s/ Brian Tessler, Attorney-in-Fact
Signature date: 12 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRWD transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +45,000
Change %: +25%
Price: $0.000000
Shares after: 228,313
Date: 10 Jun 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Footnote F2

Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.

SEC remarks

Exhibit 24 - Power of Attorney